Summit Therapeutics, Inc. shares rebounded in after-hours trading on Monday after a 14% selloff during regular hours, with ...

Truist Financial analyst Richard Newitter maintained a Buy rating on Penumbra (PEN – Research Report) on February 23 and set a price target of ...

In a report released on February 23, Youssef Squali from Truist Financial maintained a Buy rating on Wayfair (W – Research Report), with a ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $7.5, along with a high estimate of $9.00 and a low estimate of $5.00. A decline of 24.17% ...

Home Depot and Lowe's have a low bar to clear for their respective fiscal fourth-quarter earnings reports tomorrow and ...

The Atlanta Braves are adding a food hall and bar to the right-field concourse of Truist Park in concert with food and ...

Truist Financial Corp lifted its holdings in shares of Curtiss-Wright Co. (NYSE:CW – Free Report) by 6.2% during the 4th ...

Truist Financial Corp trimmed its position in shares of Stifel Financial Corp. (NYSE:SF – Free Report) by 39.4% during the ...

The legendary investor expressed his inclination for equities even after selling large chunks of Berkshire Hathaway's ...

The commission voted 6-0 to recommend passage of Ordinance 2025-0074, which would allow for an exception to Downtown zoning ...

The trial data, which was reported on February 18, 2025, also suggested potential cardiac benefits from the therapy. The company mentioned that SGT-003 has been well-tolerated with no serious adverse ...

We recently published a list of 12 Best Financial Sector Dividend Stocks To Buy Right Now In this article, we are going to ...